Skip to search boxSkip to navigationSkip to main content

The genetics of Mullerian aplasia

*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome consists of Mullerian aplasia with or without other anomalies, most commonly renal and skeletal. The genetic etiology of MRKH syndrome is unknown for most patients, but supportive evidence exists for heterozygous mutations in WNT4, LHX1, and HNF1B. Chromosomal microarray analyses have demonstrated chromosomal regions with copy number variants in multiple patients-deletions in17q12 and 16p11.2, and either deletions or duplications in 22q11.2. Genomic analyses of expression and methylation have also suggested potential molecular pathways. Positional cloning in MRKH patients with chromosomal rearrangements and exome sequencing are likely to result in new genes. Although some single gene defects and copy number variant regions have been identified, the molecular basis for the vast majority of MRKH remains unknown.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 411-419 (9 pages)

Journal (Volume, Issue Number)

Expert Review of Endocrinology and Metabolism (Volume 9, Issue 4)

Publication milestones

  • Published - 07/2014

Publication status

Published - 07/2014

ISSN

1744-6651

Publication IDs

  • Scopus: 84903213876

Publication metrics

Metrics

SciVal
FWCI
0.11
SciVal
Author count
1
SciVal
citations
4
SciVal
Paper percentile
50
Scopus
citations
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
19
Citation count
7

Funding Details

LCL was supported from NIH grant HD33004 for this work. The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
FunderFunding number
NIH
HD33004